A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCL

Clinical trial NCT05138458 · SUSPENDED

Trial details

NCT number: NCT05138458
Sponsor: Myeloid Therapeutics
Status: SUSPENDED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoma, T-Cell, Peripheral Lymphoma, T-Cell, Cutaneous Mycosis Fungoides Adoptive Cellular Immunotherapy Cell Therapy

Start date: 2021-12-15
Primary completion: 2024-11-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.